Neonatal myocardial hypertrophy

1. Alp H, Karatas Z, Baysal T. Transient severe isolated right ventricular hypertrophy in neonates. J Clin Neonatol 2014; 3 (3): 161–163. doi: 10.4103/2249-4847.140405

2. Aslam M, Christou HA. Intrauterine closure of the ductus drteriosus: Implications for the neonatologist, Am J Perinatol 2009; 26: 473–478. doi: 10.1055/s-0029-1214247

3. Boyd SM, Rileay KL, Giesinger RE, McNamara P. Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: Case series. J Perinatol 2020. doi: 10.1038/s41372-020-00824-7

4. Carter BS, DiGiacomo JE, Balderston SM, Wiggins JV, Merenstein GB. Disproportionate septal hypertrophy associated with erythroblastosis fetalis. Arch Pediatr & Adol Med 1990; 144(11): 1225–1228. doi: 10.1001/archpedi.1990.021503

5. Codazzi AC, Ippolito R, Novara C, Tondina E, Cerbo RM, Tzialla C. Hypertrophic cardiomyopathy in infant newborns of diabetic mother: A heterogeneous condition, the importace of anamnesis, physical examination and follow-up. Ital J Pediatr 2021; 47: 197. doi: 10.1186/s13052-021-01145-x

6. Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL and Cochrane neonatal group. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev 2017; 10: CD001145. doi: 10.1002/14651858.CD001145.pub4

7. Kucera J, Kucerova I, Cunat V. Non-immune hydrops fetalis – case report. Ultrasound Obstet Gynaecol 2006; 28(4): 555. doi: 10.1002uog.3562

8. Levy PT, Tissot C, Horsberg Eriksen B, Nestaas E, Rogerson S, McNamara P, El-Khuffash, de Boode WP. Application of neonatologist performed echocardiography in the assessment and management of neonatal heart failure unrelated to congenital heart disease. Pediatric Research 2018; 84: 78–88. doi: 10.1038/ s41390-018-0075-z

9. Manning N, Archer N. Cardiac manifestations of twin–to–twin transfusion syndrome. Twin Res Human Gen 2016; 19(3): 246–254. doi:10.1017/thg.2016.20

10. Oberhoffer R, Grab D, Keckstein J, Högel J, Terinde R, Lang D. Cardiac changes in fetuses secondary to immune hemolytic anemia and their relation to hemoglobin and catecholamine concentrations in fetal blood. Ultrasound Obstet Gynecol 1999; 13: 396–400. doi: 10.1046/j.1469-0705.1999.13060396.x

11. Seok H, Oh JH. Hypertrophic cardiomyopathy in infants from the perspective of cardiomyocyte maturation. Korean Circ J 2021; 51(9): 733–751. doi: 10.4070/kcj.2021.0153

12. Stegeman R, Pauuw ND, de Graaf R, van Loon RLE, Termote JUM, Breur MPJ. The etiology of cardiac hypertrophy in infants. Scientific Reports 2021; 11(1). doi: 10.1038/s41598-021-90128-3

13. Vaillant MC, Chantepie A, Casasoprana A, Chamboux C, Suc AL, Gold F, Laugier J. Transient hypertrophic cardiomyopathy in neonates after acute fetal distress. Pediatr Cardiol 1997; 18(1), 52–56. doi: 10.1007/s002469900110

14. Vrselja A, Pillow JJ, Black MJ. Effect of preterm birth on cardiac and cardiomyocyte growth and the consequences of antenatal 3896. doi: 10.3390/jcm10173896

15. Yoda H. Fetal and neonatal circulatory disorders in twin to twin transfusion syndrome. J Nippon Med Sch 2019; 86: 192–200. doi: 10.1272/jnms.JNMS.2019_86-301